Who is most at risk of developing cervical cancer?
Cervical cancer is more common among groups of women who are less likely to have access to screening for cervical cancer. Those populations are more likely to include Black women, Hispanic women, American Indian women, and women from low-income households. Oral contraceptives.
Do genetics play a role in cervical cancer?
Genetic changes in several classes of genes have been linked to cervical cancer. Tumor necrosis factor (TNF) is involved in initiating the cell commitment to apoptosis, and the genes TNFa-8, TNFa-572, TNFa-857, TNFa-863, and TNF G-308A have been associated with a higher incidence of cervical cancer.
What cancers can run in the family?
This inherited risk for cancer is caused by a small change (called a mutation) in a gene, which can be passed from one generation to the next in a family.
Some cancers that can be hereditary are:
- Breast cancer.
- Colon cancer.
- Prostate cancer.
- Ovarian cancer.
- Uterine cancer.
- Melanoma (a type of skin cancer)
- Pancreatic cancer.
Can cervical cancer be cured completely?
Cervical cancer is generally viewed as treatable and curable, particularly if it is diagnosed when the cancer is in an early stage. This disease occurs in the cervix, or the passageway that joins the lower section of the uterus to the vagina.
What’s the most common age to get cervical cancer?
Cervical cancer is most frequently diagnosed in women between the ages of 35 and 44 with the average age at diagnosis being 50 . It rarely develops in women younger than 20. Many older women do not realize that the risk of developing cervical cancer is still present as they age.
How quickly can you get cervical cancer?
Once infected with HPV, it can take 15 to 20 years for cervical cancer to develop, or 5 to 10 years if you have a weakened immune system. HPV may be more likely to progress to cervical cancer if you smoke or have other sexually transmitted infections (STIs) such as chlamydia, gonorrhea, or herpes simplex.
Which gene is responsible for cervical cancer?
Novel mutated genes in cervical cancer include MED1, ERBB3, CASP8, HLA-A, and TGFBR2. Some genomic changes in cervical cancer indicate the disease may be treated with available drugs: Altered genes involved in regulating the immune system including CD274 and PDCD1LG2 may be targeted by immunotherapeutic agents.